Aggrade

Founded in 2014 by co-founders Giovanni Politi and Vincenzo Politi, Aggrade is a biotechnology company headquartered in Camberley, United Kingdom. The firm operates within the pharmaceutical and life sciences sectors, focusing on the development of processing technology for the biopharma industry.

Aggrade specializes in creating eco-friendly and effective granulation methods for the formulation of pharmaceutical drugs and nutraceutical products. The company's core offering revolves around aerodynamic technologies designed to advance the manufacturing process for its clients. This enables biopharma and nutraceutical companies to access tools that support the delivery of advanced healthcare services.

The company is privately held and venture capital-backed, having completed an early-stage VC funding round on September 21, 2016, which raised approximately $392,000. Investors in the company include Aldabra Capital, Embed Capital, Medeopart, and Medeor Associates.

Keywords: pharmaceutical processing, biotechnology, biopharma, granulation methods, drug formulation, nutraceutical products, aerodynamic technology, life sciences, drug discovery, venture capital-backed, pharmaceutical manufacturing, healthcare services technology